Sanai Health Industry Group Company Limited (HKG:1889)

HKG:1889 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	85.22	107.77	175.92	67.61	121.4
Revenue Growth (YoY)	-20.92%	-38.74%	160.21%	-44.31%	48.32%
Cost of Revenue	68.35	78.6	84.41	27.16	90.71
Gross Profit	16.86	29.17	91.51	40.45	30.7
Selling, General & Admin	32.31	14.17	19.11	14.84	14.84
Operating Expenses	31.51	10.74	32.16	15.72	14.84
Operating Income	-14.65	18.43	59.35	24.72	15.85
Interest Expense	-2.2	-2.03	-1.79	-	-
Interest & Investment Income	0.57	0.45	0.08	0.71	0.58
Earnings From Equity Investments	-0.46	-	-	-	-
Currency Exchange Gain (Loss)	-	-	-	0.05	0.04
Other Non Operating Income (Expenses)	3.91	-0.02	2.03	0.01	0.21
EBT Excluding Unusual Items	-12.82	16.83	59.67	25.5	16.68
Gain (Loss) on Sale of Assets	-0.12	-	-2.48	-	-0.02
Other Unusual Items	-	2.55	-1.41	-	-
Pretax Income	-12.94	19.38	55.77	25.5	16.65
Income Tax Expense	0.97	8.44	20.57	8.63	5.16
Earnings From Continuing Operations	-13.91	10.94	35.2	16.88	11.49
Earnings From Discontinued Operations	17.31	2.43	-	-	-
Net Income to Company	3.4	13.37	35.2	16.88	11.49
Minority Interest in Earnings	1.49	5.27	-5.98	-7.85	-5.07
Net Income	4.89	18.63	29.22	9.03	6.42
Net Income to Common	4.89	18.63	29.22	9.03	6.42
Net Income Growth	-73.75%	-36.23%	223.73%	40.53%	-94.11%
Shares Outstanding (Basic)	145	128	123	123	123
Shares Outstanding (Diluted)	145	152	144	123	123
Shares Change (YoY)	-4.19%	5.08%	17.66%	-	-
EPS (Basic)	0.03	0.15	0.24	0.07	0.05
EPS (Diluted)	0.03	0.13	0.22	0.07	0.05
EPS Growth	-73.55%	-43.10%	208.51%	38.51%	-94.11%
Free Cash Flow	10.63	320.61	-56.22	-38.81	-1.86
Free Cash Flow Per Share	0.07	2.11	-0.39	-0.32	-0.01
Gross Margin	19.79%	27.07%	52.02%	59.82%	25.28%
Operating Margin	-17.19%	17.11%	33.73%	36.57%	13.06%
Profit Margin	5.74%	17.29%	16.61%	13.35%	5.29%
Free Cash Flow Margin	12.47%	297.50%	-31.95%	-57.40%	-1.53%
EBITDA	-12.54	21.56	62.59	28.14	19.34
EBITDA Margin	-14.72%	20.01%	35.58%	41.62%	15.93%
D&A For EBITDA	2.1	3.13	3.24	3.41	3.49
EBIT	-14.65	18.43	59.35	24.72	15.85
EBIT Margin	-17.19%	17.11%	33.73%	36.57%	13.06%
Effective Tax Rate	-	43.55%	36.89%	33.82%	30.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.